hCAR regulated induction of CYP2B6 and CYP3A4 in HPHs.
(A) CYP2B6
and CYP3A4 mRNA levels were measured in HPHs prepared from human liver
donors (HL-#151). The HPHs were treated with CITCO (0.5, 1, and 5
μM), PB (1 mM), RIF (10 μM), DL5050 (0.5, 1, and 5 μM), 18 (0.5, 1, and 5 μM), or vehicle control. (B) Representative
immunoblots of CYP2B6 and CYP3A4 proteins in HPHs from liver donors
#151. RT-PCR data obtained from three independent experiments were
expressed as mean ± SD normalized against vehicle control.